30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Struthers Richard Scott

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
10 20% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 60%
Success rate 73%
Average holding period 220
Transactions 28
Struthers Richard Scott's trades of Crinetics Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-18 2026-03-16 PlS Planned sale
15,920 -25.5%
125.43
US$3,832,461
15,920 -25.5% 125.43 US$3,832,461
2026-03-18 2026-03-16 PlS Planned sale
48,527 -14.7%
167.09
US$4,715,610
48,527 -14.7% 167.09 US$4,715,610
2026-03-16 2026-03-16 PrS Proposed sale
20,324
66.39
US$4,082,383
20,324 66.39 US$4,082,383
2025-09-30 2025-09-26 PlS Planned sale
4,000 -3.6%
45.00
US$180,000
4,000 -3.6% 45.00 US$180,000
2025-09-26 2025-09-26 PrS Proposed sale
4,000
45.00
US$180,000
4,000 45.00 US$180,000
2025-03-21 2025-03-19 PlS Planned sale
875 -0.3%
34.83
US$30,476
875 -0.3% 34.83 US$30,476
2025-03-21 2025-03-19 PlS Planned sale
16,463 -4.8%
34.17
US$562,541
16,463 -4.8% 34.17 US$562,541
2024-12-04 2024-12-02 PlS Planned sale
10,000 -9.1%
57.57
US$575,700
10,000 -9.1% 57.57 US$575,700
2024-12-02 2024-12-02 PrS Proposed sale
10,000
57.27
US$572,700
10,000 57.27 US$572,700
2024-05-10 2024-05-08 PlS Planned sale
107,448 -29.4%
49.40
US$5,307,931
107,448 -29.4% 49.40 US$5,307,931
2024-05-10 2024-05-08 PlS Planned sale
107,448 -29.4%
49.40
US$5,307,931
107,448 -29.4% 49.40 US$5,307,931
2024-05-08 2024-05-08 PrS Proposed sale
107,448
49.40
US$5,308,092
107,448 49.40 US$5,308,092
2024-04-08 2024-04-04 PlS Planned sale
40,951 -14.7%
49.17
US$2,013,561
40,951 -14.7% 49.17 US$2,013,561
2024-04-04 2024-04-04 PrS Proposed sale
40,951
49.17
US$2,013,552
40,951 49.17 US$2,013,552
2023-11-06 2023-11-03 S Sale
199,082 -59.5%
30.56
US$6,083,946
199,082 -59.5% 30.56 US$6,083,946
2023-11-03 2023-11-03 PrS Proposed sale
199,082
29.95
US$5,962,505
199,082 29.95 US$5,962,505
2023-11-06 2023-11-02 S Sale
918 -0.7%
29.95
US$27,494
918 -0.7% 29.95 US$27,494
2023-11-02 2023-11-02 PrS Proposed sale
918
29.80
US$27,356
918 29.80 US$27,356
2023-07-13 2023-07-13 PrS Proposed sale
14,157
20.35
US$288,154
14,157 20.35 US$288,154
2023-07-13 2023-07-13 S Sale
14,157 -2.2%
20.35
US$288,095
14,157 -2.2% 20.35 US$288,095
2023-07-13 2023-07-12 S Sale
11,459 -1.7%
20.17
US$231,128
11,459 -1.7% 20.17 US$231,128
2023-07-12 2023-07-12 PrS Proposed sale
11,459
20.17
US$231,172
11,459 20.17 US$231,172
2023-07-13 2023-07-11 S Sale
24,384 -3.6%
20.14
US$491,094
24,384 -3.6% 20.14 US$491,094
2023-07-11 2023-07-11 PrS Proposed sale
24,384
20.14
US$491,118
24,384 20.14 US$491,118
2023-06-21 2023-06-16 S Sale
50,000 -6.8%
20.81
US$1,040,500
50,000 -6.8% 20.81 US$1,040,500
2023-06-16 2023-06-16 PrS Proposed sale
50,000
20.51
US$1,025,335
50,000 20.51 US$1,025,335
2022-04-15 2022-04-13 PlS Planned sale
69,176 -8.6%
27.53
US$1,904,256
69,176 -8.6% 27.53 US$1,904,256
2022-04-15 2022-04-13 PlS Planned sale
44,793 -5.3%
26.52
US$1,188,040
44,793 -5.3% 26.52 US$1,188,040
2022-04-15 2022-04-13 PlS Planned sale
24,674 -2.8%
25.42
US$627,329
24,674 -2.8% 25.42 US$627,329
2022-04-07 2022-04-05 PlS Planned sale
21,357 -2.4%
25.34
US$541,225
21,357 -2.4% 25.34 US$541,225
2020-12-04 2020-12-03 B Purchase
4,000 +inf%
13.10
US$52,400
4,000 +inf% 13.10 US$52,400
2020-12-04 2020-12-02 B Purchase
1,000 +inf%
12.60
US$12,600
1,000 +inf% 12.60 US$12,600
2020-07-17 2020-07-16 S Sale
17,500 -1.9%
14.46
US$253,108
17,500 -1.9% 14.46 US$253,108
2020-07-17 2020-07-15 S Sale
17,500 -1.9%
15.30
US$267,722
17,500 -1.9% 15.30 US$267,722